ANI Pharmaceuticals is trading 6.81% down at $77.00 in pre-market after no confirmed company-specific overnight catalyst was identified.
- Second-quarter 2026 results are scheduled for release at 8:00 a.m. ET on August 7, 2026, making pre-market positioning ahead of earnings the most relevant immediate event.
- Healthcare is higher pre-market, so the decline is not explained by sector weakness.